These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 15389193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E, Ito-Ihara T, Ono T, Imai E, Yamagata K, Akamatsu A, Suzuki K.
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [Abstract] [Full Text] [Related]

  • 3. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
    Chrissafidou A, Malek M, Musch E.
    Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
    [Abstract] [Full Text] [Related]

  • 4. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy.
    Tamburin S, Zanette G.
    Pain Med; 2009 Nov; 10(8):1476-80. PubMed ID: 19788714
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
    Zinman L, Bril V.
    Ann N Y Acad Sci; 2008 Nov; 1132():264-70. PubMed ID: 18567877
    [Abstract] [Full Text] [Related]

  • 10. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.
    Hagman JH, Carrozzo AM, Campione E, Romanelli P, Chimenti S.
    J Dermatolog Treat; 2001 Mar; 12(1):19-22. PubMed ID: 12171682
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S, Riefolo A, Biscione R, Goretti E, Cattabriga I, Grillone G, Bacchi-Reggiani L, Pacini D.
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E, Kessel A, Shoenfeld Y.
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
    Lavrnić DB, Stojanović V, Marinković Z, Pavlović S, Vidaković A, Apostolski S.
    Srp Arh Celok Lek; 1995 Apr; 123(5-6):146-8. PubMed ID: 17974459
    [Abstract] [Full Text] [Related]

  • 16. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B, Posch C, Vujic I, Sesti A, Sobotka S, Rappersberger K.
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [Abstract] [Full Text] [Related]

  • 19. Response of livedoid vasculitis to intravenous immunoglobulin.
    Ravat FE, Evans AV, Russell-Jones R.
    Br J Dermatol; 2002 Jul; 147(1):166-9. PubMed ID: 12100203
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.